Skip to main content
Explore our brands An Informa TechTarget Publication
close search
site logo

Perrigo enters softgel space buying ex-Banner operations for $34m from Patheon

Published May 16, 2015

Recommended Reading

Editors' picks

  • A technician wearing a blue mask works in a laboratory.
    Image attribution tooltip
    Kevin Frayer via Getty Images
    Image attribution tooltip
    China competition

    Drugs from China are reshaping biotech. Track the licensing deals here.

    Bristol Myers’ alliance with Hengrui ranks as the second-largest licensing pact of its kind since the start of 2025, trailing only AstraZeneca’s $18.5 billion tie-up with CSPC in January, according to BioPharma Dive data.

    By Ben Fidler • Updated May 19, 2026
  • A stylized illustration of test tubes in front of a red line on a chart going up and to the right.
    Image attribution tooltip
    Adeline Kon/BioPharma Dive/BioPharma Dive
    Image attribution tooltip
    Deep Dive // Emerging biotech

    Biotech startups are built on venture capital. Track funding rounds here.

    Two biotechs — radiopharmaceuticals specialist Full-Life Technologies and immune drugmaker Accro Bioscience — raised $160 million combined in a pair of equity financings announced Monday.

    By Gwendolyn Wu, Ben Fidler, Ned Pagliarulo and Julia Himmel • Updated May 19, 2026

Company Announcements

View all | Post a press release
Avalere Health launches ‘Within Reach’, a new oncology anthology about what it really means to…
From Avalere Health
May 20, 2026
Avalere Health logo
PSI CRO Establishes Mexico Office Expanding Access To One Of Latin America’s Highest-value Pat…
From PSI
May 13, 2026
PSI logo
Zymewire Appoints Industry Veteran Heather N. Sugrue as Managing Director
From Zymewire
May 12, 2026
Zymewire logo
Almac Clinical Technologies Named “Best Clinical Trial Technology Solution Provider” in 2026 M…
From Almac Group
May 07, 2026
Almac Group logo
Editors' picks
  • A technician wearing a blue mask works in a laboratory.
    Image attribution tooltip
    Kevin Frayer via Getty Images
    Image attribution tooltip
    China competition

    Drugs from China are reshaping biotech. Track the licensing deals here.

    Bristol Myers’ alliance with Hengrui ranks as the second-largest licensing pact of its kind since the start of 2025, trailing only AstraZeneca’s $18.5 billion tie-up with CSPC in January, according to BioPharma Dive data.

    By Ben Fidler • Updated May 19, 2026
  • A stylized illustration of test tubes in front of a red line on a chart going up and to the right.
    Image attribution tooltip
    Adeline Kon/BioPharma Dive/BioPharma Dive
    Image attribution tooltip
    Deep Dive // Emerging biotech

    Biotech startups are built on venture capital. Track funding rounds here.

    Two biotechs — radiopharmaceuticals specialist Full-Life Technologies and immune drugmaker Accro Bioscience — raised $160 million combined in a pair of equity financings announced Monday.

    By Gwendolyn Wu, Ben Fidler, Ned Pagliarulo and Julia Himmel • Updated May 19, 2026
This website is owned and operated by Informa TechTarget, a global network that informs, influences and connects the world's technology buyers and sellers.

© 2025 TechTarget, Inc. or its subsidiaries. All rights reserved. An Informa PLC company.
Privacy policy | Terms of use | Take down policy | Cookie Preferences / Do Not Sell